Spatial transcriptomics of glioblastoma defines biologically and clinically significant reprogramming patterns across...

Area of Science:

• Neuro-oncology
• Cancer Biology
• Genomics

Background:

• Glioblastoma (GBM) is a lethal brain tumor characterized by significant intratumoral heterogeneity.
• The tumor microenvironment (TME) contains diverse cellular states and interactions that influence GBM behavior and treatment resistance.

Purpose of the Study:

• To define GBM biological reprogramming, TME composition, and cell-cell interactions within specific spatial regions.
• To integrate gene co-expression network modules with cell-cell communication data using a novel spatially informed approach.
• To identify spatial niche-specific vulnerabilities for targeted combination therapies.

Main Methods:

• Analysis of gene co-expression network modules to identify biological reprogramming.
• Integration of spatial transcriptomics data (Visium) with cell-cell communication analysis.
• Mapping of molecular and cellular features to spatially defined regions of the Ivy Glioblastoma Atlas Project.

Main Results:

• Validated previous findings on GBM heterogeneity and spatial organization.
• Provided novel insights into spatial patterns of transcription factor regulation and pathway activity.
• Identified specific cell-cell interactions and biological reprogramming within distinct GBM niches.

Conclusions:

• Spatial heterogeneity is a critical factor in glioblastoma progression and treatment response.
• A spatially informed approach can reveal niche-specific vulnerabilities.
• The study provides a valuable dataset and framework for future GBM research and therapeutic development.